Europe's sport university specializing in exercise interventions for cancer, fatigue, and aging — with strong clinical trial design expertise.
Deutsche Sporthochschule Köln (German Sport University Cologne) is Europe's only dedicated sport university, combining sports science with clinical research — particularly in exercise-based therapies for chronic disease. Their H2020 work focuses on using structured exercise interventions to improve outcomes for cancer patients, people with multiple sclerosis, and aging populations. They bring deep expertise in designing and running randomized controlled trials that test whether precision exercise programs can reduce fatigue, improve quality of life, and support patients through treatment.
PREFERABLE targets exercise for metastatic breast cancer fatigue, FORTEe develops precision exercise training for childhood cancer, and MS Fatigue_Therapy addresses fatigue in neurological disease.
Three projects (MS Fatigue_Therapy, PREFERABLE, FORTEe) explicitly target fatigue as a clinical endpoint, suggesting deep methodological expertise in fatigue assessment.
my-AHA focused on active and healthy aging solutions, connecting sport science to gerontology.
ELSAH explored electronic smart patch systems for molecular biomarker self-testing, indicating a move toward digital health technology integration.
PREFERABLE and FORTEe are both structured as large-scale RCTs, showing strong clinical trial methodology capability.
Their early H2020 work (2016-2018) addressed broad topics — healthy aging and MS fatigue measurement — without a tight thematic focus. From 2019 onward, a clear specialization emerged: exercise interventions for cancer patients, spanning adult metastatic breast cancer (PREFERABLE), childhood cancer (FORTEe), and digital biomarker monitoring (ELSAH). The trajectory shows a university sharpening its niche from general sport-health research toward precision exercise medicine integrated with digital health tools.
They are converging on exercise as medicine for cancer, increasingly combined with digital monitoring and augmented reality — expect future projects at the intersection of exercise oncology and health tech.
DSHS Köln operates primarily as a specialist partner (4 of 5 projects), contributing exercise science and clinical trial expertise to larger consortia rather than leading them. Their one coordinator role was a focused MSCA fellowship, suggesting they lead smaller investigator-driven studies but join as domain experts in big multi-partner RIAs. With 49 unique partners across 17 countries, they connect widely rather than returning to the same collaborators, making them accessible to new consortium builders.
They have collaborated with 49 distinct partners across 17 countries, indicating a broad European network. This breadth relative to only 5 projects suggests they join large, diverse consortia rather than tight recurring partnerships.
As Europe's only standalone sport university, DSHS Köln occupies a unique niche: they are not a medical school doing exercise research on the side, but a sport science institution with deep clinical trial capability. This makes them an ideal partner when a consortium needs rigorous exercise intervention design — they bring both the scientific methodology and the physical training infrastructure. Their combination of paediatric and adult exercise oncology expertise is rare in the EU research landscape.
